Data & AI for Healthcare & Pharmaceuticals

Transforming and creating value for pharmaceuticals, hospitals, clinicals, telemedicine, biotechnologies through the power of data & AI.

The global AI in healthcare market was valued at $19.54 billion in 2023 and is projected to reach $490.96 billion by 2032, with a CAGR of 43.2% (Grand View Research) (Fortune Business Insights).

Operational Efficiency: AI improves data analysis, with machine learning helping to structure 97% of previously unused healthcare data. (Healthtech Solutions).
Medical Imaging and Diagnostics: AI tools enhance diagnostic accuracy and reduce interpretation times for medical images, aiding in early disease detection. (Healthtech Solutions) (Grand View Research).

Drug Discovery and Development: AI reduces drug discovery times from 5-6 years to just one year, significantly speeding up the process. (Grand View Research).
Personalized Medicine: AI analyzes genomic and medical data to develop personalized treatment plans, improving treatment efficacy. (Fortune Business Insights).

SANOFI CHC Precision Marketing – Industrialising the deployment of data-driven...

PIERRE FABRE GROUP Accelerating online growth with a global e-Retail...

The Carnot CALYM Institute Fighting against lymphoma with Artificial Intelligence

SANOFI CHC Driving Digital Transformation With Precision Marketing‌‌

PIERRE FABRE COSMÉTIQUES Using Precision Marketing to change the customer...

November 21th, 2024
Station F, Paris

We are data, AI and digital experts sharing our insights and latest market updates on the healthcare and pharmaceutical sector.

Leaders’ POV: Accelerating drug innovation through AI at SERVIER – AI for Health Summit
Read more
AMGEN, BIOGEN, Johnson & Johnson, USE&SHARE, APHP at the AI for Health Summit – Strategic vision for rare diseases
Read more
Revolutionizing Drug Development: Unleashing the Power of Artificial Intelligence in Clinical Trials
Read more
Marketing Mix Modeling in Pharmaceuticals: challenges and solutions
Read more